Skip to main content


Table 2 High retention rates were evidenced across the trials in KwaZulu-Natal.

From: Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa

Trial Retention
MIRA (average at two sites) 94%
Carraguard 97%
CS 92%
HPTN 035 (average at two sites) 95%
MDP 301 (average at three sites) 96%